Hepatitis Case Report

778 Words2 Pages

Drug-induced hepatitis is a common disease that affects patients taking certain type of medications. The presentation of these patients include jaundice, abdominal pain, nausea and vomiting.3 This case report will describe a middle aged gentleman with Acquired Immunodeficiency Syndrome (AIDS), Pulmonary Tuberculosis (PTB) and Hepatitis C who had just started on Highly Active AntiRetroviral Therapy (HAART) and had been rechallenged with antituberculosis drugs (anti-TB) who presented with signs of liver failure. This case highlights that there may be many factors that might cause the hepatotoxicity and we should know how to exclude which drug that might cause it and all other AIDS related complications.
Introduction
In patients with HIV, abnormal levels of liver enzymes are common and this might be due to multiple factors such as medication toxicity and coinfections with other liver disease. There are evidence that chronic viral hepatitis (hepatitis B or C) is associated with increased risk of antiretroviral-associated hepatotoxicity.7
As chronic viral hepatitis has a high prevalence in patients with HIV, clinicians should assess the risk of development of hepatotoxicity in these patients whenever HAART is initiated.7

Introduction of HAART has led to significant reductions in mortality and morbidity associated with HIV infection. However, even with the reduction in mortality and morbidity, there are still some adverse effects caused by these drugs. Hepatotoxicity is commonly seen in patients taking Non- Nucleoside Reverse Transcriptase Inhibitors (NNRTI), a drug used in HAART. Drug-induced liver injury is responsible for more than 50% of cases of acute liver injury in the United States. Furthermore, patients with concurrent Hepatit...

... middle of paper ...

... and micronodular cirrhosis were observed in the liver of a patient who died of rifampicin- and pyrazinamide-induced hepatotoxicity.4
Adverse drug reactions especially in the liver usually occurs in the 2 months of starting treatment but it can occur at any time during treatment period. Also, it is difficult to differentiate drug induced hepatitis from viral hepatitis particularly if a patient is co-infected with Hepatitis B or C.4.6
The signs and symptoms of liver injury that may be found are jaundice, abdominal pain, nausea, vomiting and asthenia. However, they are not specific enough to ascertain a liver disorder.4
Also, patient with anti-TB regimen who have co-infection with Hepatitis B, C and patients with HIV with HAART therapy and anti-TB regimen is at a higher risk of developing hepatotoxicity compared to patients receiving anti-TB with no liver disease.4,5

More about Hepatitis Case Report

Open Document